TransCode Therapeutics, Inc. Company Information
TransCode Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: TransCode Therapeutics, Inc.
- Ticker: RNAZ
- Exchange: NasdaqCM
- Founded: 2016
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$3.708m
- Shares Outstanding: 6.11m
- Website: https://www.transcodetherapeutics.com
Number of Employees
Location
- TransCode Therapeutics, Inc.
- 6 Liberty Square
- Suite 2382
- Boston
- Massachusetts
- 2109
- United States
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
RNAZ | NasdaqCM (Nasdaq Capital Market) | Yes | Common Stock | US | USD | Jul 2021 |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/05/01 00:00 |
End of Day Share Price | 2024/05/01 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.